coagulation factor VIIa (recombinant)-jncw 2 MG Injection

RxCUI: 2696277
RxNorm name: coagulation factor VIIa (recombinant)-jncw 2 MG Injection
Display name: coagulation factor VIIa (recombinant)-jncw 2 MG Injection
Full name: coagulation factor VIIa (recombinant)-jncw 2 MG Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125641	Sevenfact	coagulation factor VIIa (recombinant)-jncw	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sevenfact	COAGULATION FACTOR VIIA RECOMBINANT HUMAN	Laboratoire Franais du Fractionnement et des Biotechnologies Socit Anonyme (LFB S.A.)	b23ad666-8ce0-4e0b-9eff-c6983ac5f7e6	2025-11-19	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2696277

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
b23ad666-8ce0-4e0b-9eff-c6983ac5f7e6	coagulation factor VIIa (recombinant)-jncw 2 MG Injection [PSN] · coagulation factor VIIa (recombinant)-jncw 2 MG Injection [SCD]	2	11	These highlights do not include all the information needed to use SEVENFACT ® safely and effectively. See full prescribing information for SEVENFACT ® . SEVENFACT ® [coagulation factor VIIa (recombinant)-jncw] Lyophilized Powder for Solution, for Intravenous U se Initial U.S. Approval: 2020	20251119